Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | POLB | P06746 | 1/20 | 0.57 |
| ▸ | MAPT | P10636 | 1/20 | 0.56 |
| ▸ | GAA | P10253 | 1/20 | 0.56 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.56 |
| ▸ | ADRA1D | P25100 | 3/20 | 0.55 |
| ▸ | ADRA1A | P35348 | 3/20 | 0.55 |
| ▸ | ADRA1B | P35368 | 3/20 | 0.55 |
| ▸ | F10 | P00742 | 12/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21701424 | 0.97 | GAA (0.59) | POLBMAPTGAAKMT2AADRA1D | |
| SCHEMBL21701412 | 0.92 | KMT2A (0.55) | POLBMAPTGAAKMT2AADRA1D | |
| SCHEMBL21701456 | 0.90 | POLB (0.57) | POLBMAPTGAAKMT2AF10 | |
| SCHEMBL21701423 | 0.90 | POLB (0.57) | POLBMAPTGAAKMT2AF10 | |
| SCHEMBL21701415 | 0.90 | POLB (0.67) | POLBMAPTKMT2AF10 | |
| SCHEMBL21701427 | 0.89 | MAPT (0.57) | POLBMAPTF10 | |
| SCHEMBL21701425 | 0.88 | POLB (0.55) | POLBMAPTGAAKMT2AF10 | |
| SCHEMBL21701426 | 0.87 | F10 (0.61) | POLBMAPTF10 | |
| SCHEMBL21701458 | 0.87 | MAPT (0.54) | POLBMAPTGAAKMT2AF10 | |
| SCHEMBL21701421 | 0.85 | MAPT (0.53) | POLBMAPTKMT2AF10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2020033944-A2 | NON-POLYAMINE BASED POLYAMINE TRANSPORT INHIBITORS AND THEIR USE IN THE TREATMENT OF HUMAN CANCERS | UNIVERSITY OF CENTRAL FLORIDA RESEARCH FOUNDATION, INC. (US) | 2020-02-13 | — | — | WO | disclosed |